You are viewing a plain text version of this content. The canonical link for it is here.

Posted to user@uima.apache.org by Reinhard Erich Voglmaier <re...@gsk.com.INVALID> on 2020/04/30 13:22:32 UTC

user



Reinhard E. Voglmaier

________________________________

Reinhard Erich Voglmaier, CISA
Medical Excellence and Governance Dept.


GlaxoSmithKline Spa - Pharmaceuticals
Via Fleming 2 37135 - Verona
mobile 39 349 079 8094


Email   reinhard.e.voglmaier@gsk.com<ma...@gsk.com>

gsk.it <https://www.gsk.it/>  |  Twitter<https://twitter.com/gsk_it>  | YouTube<https://www.youtube.com/channel/UC9asvkCaqykjPtg4j2lzD6w>  |  Facebook<https://www.facebook.com/GSKItalia/>

[cid:image001.png@01D0FCF6.C79046A0]


[Misc_Responsibility_DG_POS_RGB.png]
Please consider the environment before printing this email



GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.